Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost/Brinzolamide Fixed Combination in Glaucoma or Ocular Hypertension
NCT00527501Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Aug 2007
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of travoprost + brinzolamide in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Aug 2007; status: completed.
02
Drugs
travoprost + brinzolamide
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00527501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00527501.